U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C24H23Cl2N3O
Molecular Weight 440.365
Optical Activity UNSPECIFIED
Defined Stereocenters 3 / 3
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of SCH-486757

SMILES

O[C@]1(C[C@@H]2CC[C@H](C1)N2C(C3=CC=CC=C3Cl)C4=CC=CC=C4Cl)C5=NC=CC=N5

InChI

InChIKey=MQWMHMZNBGQNMT-XHNJZIHCSA-N
InChI=1S/C24H23Cl2N3O/c25-20-8-3-1-6-18(20)22(19-7-2-4-9-21(19)26)29-16-10-11-17(29)15-24(30,14-16)23-27-12-5-13-28-23/h1-9,12-13,16-17,22,30H,10-11,14-15H2/t16-,17+,24-

HIDE SMILES / InChI

Molecular Formula C24H23Cl2N3O
Molecular Weight 440.365
Charge 0
Count
MOL RATIO 1 MOL RATIO (average)
Stereochemistry EPIMERIC
Additional Stereochemistry No
Defined Stereocenters 2 / 3
E/Z Centers 0
Optical Activity UNSPECIFIED

Description

SCH486757 was invented as a selective nociceptin/orphanin FQ peptide (NOP) receptor agonist. SCH486757 participated in phase II clinical trial for the treatment of cough, however, this study was discontinued.

Approval Year

PubMed

Sample Use Guides

In Vivo Use Guide
Subjects were randomised to receive either SCH486757 100 mg, codeine 30 mg, or matched placebo twice daily for 5 days
Route of Administration: Oral
Substance Class Chemical
Record UNII
2HV668N62T
Record Status Validated (UNII)
Record Version